Crown Laboratories Achieves Remarkable Growth, Ranks Among Top 5000 Private Companies Crown Laboratories, now part of Revance, celebrated its spot at 3,991 on the 2025 Inc. 5000, showcasing impressive growth and innovation in skincare.

Crown Laboratories Achieves Remarkable Growth, Ranks Among Top 5000 Private Companies #United_States #Nashville #Inc._5000 #Crown_Laboratories #Revance

Crown Laboratories Emerges as Revance: A New Era in Aesthetic Innovation Crown Laboratories has rebranded as Revance, marking a strategic shift in their mission and product offerings in the skincare and aesthetics industry.

Crown Laboratories Emerges as Revance: A New Era in Aesthetic Innovation #USA #Nashville #Crown_Laboratories #Revance #Aesthetics

Crown Laboratories Unveils Innovative Sarna® Eczema Relief Skin Protectant Lotion for Sensitive Skin Crown Laboratories launches Sarna® Eczema Relief Skin Protectant Lotion, enhancing its portfolio with a powerful solution for eczema-prone skin.

Crown Laboratories Unveils Innovative Sarna® Eczema Relief Skin Protectant Lotion for Sensitive Skin #USA #Crown_Laboratories #Johnson_City,_Tennessee #Sarna_Eczema_Relief #skin_protectant

Crown Laboratories Welcomes Adelle Walker as New Chief Marketing Officer for Aesthetics Division Crown Laboratories has appointed Adelle Walker as Chief Marketing Officer. She aims to enhance growth and innovation in the aesthetics sector.

Crown Laboratories Welcomes Adelle Walker as New Chief Marketing Officer for Aesthetics Division #USA #Crown_Laboratories #Johnson_City #Adelle_Walker #Aesthetics

Crown Laboratories Welcomes Adrianne Shapira to Board, Enhancing Future Growth Potential in Skincare Crown Laboratories proudly announces Adrianne Shapira's appointment to its Board of Directors, enhancing its strategic vision in the skincare industry.

Crown Laboratories Welcomes Adrianne Shapira to Board, Enhancing Future Growth Potential in Skincare #United_States #Crown_Laboratories #Johnson_City #Adrianne_Shapira #skincare_board

StriVectin Expands Peptide Plump Collection with New Collagen Cushion Cream for Youthful Skin Crown Laboratories introduces StriVectin's latest product, Peptide Plump Collagen Cushion Cream, designed to rejuvenate aging skin with advanced peptide technology.

StriVectin Expands Peptide Plump Collection with New Collagen Cushion Cream for Youthful Skin #USA #Crown_Laboratories #StriVectin #Johnson_City #Peptide_Plump

Crown Laboratories Finalizes Acquisition of Revance Therapeutics Enhancing Skincare Innovation Crown Laboratories has successfully completed the acquisition of Revance Therapeutics, reinforcing its leadership in innovative skincare solutions.

Crown Laboratories Finalizes Acquisition of Revance Therapeutics Enhancing Skincare Innovation #United_States #Skincare #Crown_Laboratories #Johnson_City #Revance

Crown Laboratories and Revance Therapeutics Finalize Tender Offer Details Amid Acquisition Developments Crown Laboratories and Revance Therapeutics concluded their tender offer process, paving the way for an anticipated acquisition that is set to unfold shortly.

Crown Laboratories and Revance Therapeutics Finalize Tender Offer Details Amid Acquisition Developments #USA #Crown_Laboratories #Revance_Therapeutics #Johnson_City #Acquisition_Update

Revance Shareholders Urged to Support Crown's Acquisition by February 4 Deadline Revance stockholders are reminded to submit their shares for Crown's cash offer of $3.65 before the February 4 deadline to ensure a successful transaction.

Revance Shareholders Urged to Support Crown's Acquisition by February 4 Deadline #United_States #Crown_Laboratories #Revance_Therapeutics #Teoxane #Nashville,_Tennessee

Crown Laboratories Revamps Blue Lizard Sunscreen with Sustainable Formulas and Packaging Crown Laboratories has rebranded its iconic Blue Lizard Australian Sunscreen with updated formulas and eco-friendly packaging, highlighting their commitment to sun protection.

Crown Laboratories Revamps Blue Lizard Sunscreen with Sustainable Formulas and Packaging #USA #Crown_Laboratories #Johnson_City #Blue_Lizard #Sunscreen

Crown Laboratories and Revance Increase Merger Offer to Enhance Shareholder Value Crown Laboratories and Revance Therapeutics have amended their merger agreement, raising the offer to $3.65 per share and extending the tender offer deadline to February 4, 2025.

Crown Laboratories and Revance Increase Merger Offer to Enhance Shareholder Value #United_States #Nashville #Merger_Agreement #Crown_Laboratories #Revance_Therapeutics

Crown Laboratories Extends Cash Tender Offer for Revance Therapeutics Shares Until January 28, 2025 Crown Laboratories has extended its cash tender offer for Revance Therapeutics, increasing the timeframe for share acquisition to January 28, 2025.

Crown Laboratories Extends Cash Tender Offer for Revance Therapeutics Shares Until January 28, 2025 #USA #Skincare #Crown_Laboratories #Revance_Therapeutics #Johnson_City

Crown Laboratories Initiates Tender Offer for Revance Therapeutics Shares at $3.10 Each Crown Laboratories has launched a tender offer to acquire Revance Therapeutics, proposing $3.10 per share. The move aims to provide immediate liquidity for stockholders.

Crown Laboratories Initiates Tender Offer for Revance Therapeutics Shares at $3.10 Each #USA #Skincare #Crown_Laboratories #Revance_Therapeutics #Johnson_City

Crown Laboratories and Revance Reinvent Merger Agreement Amid Industry Shifts Crown Laboratories and Revance Therapeutics have unveiled their updated merger agreement, highlighting their commitment to innovative skincare solutions and expansion.

Crown Laboratories and Revance Reinvent Merger Agreement Amid Industry Shifts #USA #Crown_Laboratories #Revance_Therapeutics #DAXXIFY #Johnson_City,_Tennessee